XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
Subscription agreements
At-the-market issuance
Reverse asset acquisition
Pre-Merger Financing
Common Stock
Common Stock
Subscription agreements
Common Stock
At-the-market issuance
Common Stock
Reverse asset acquisition
Common Stock
Pre-Merger Financing
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Subscription agreements
Additional Paid-in Capital
At-the-market issuance
Additional Paid-in Capital
Reverse asset acquisition
Additional Paid-in Capital
Pre-Merger Financing
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018           4,960,552                        
Beginning balance at Dec. 31, 2018 $ (12,709,539)         $ 49,606         $ 0 $ 18,477,598         $ 451 $ (31,237,194)
Increase (Decrease) in Stockholders' Equity                                    
Stock-based compensation expense 415,202                     415,202            
Foreign currency translation adjustment (282)                               (282)  
Net loss (6,312,606)                                 (6,312,606)
Ending balance (in shares) at Mar. 31, 2019           4,960,552                        
Ending balance at Mar. 31, 2019 (18,607,225)         $ 49,606         0 18,892,800         169 (37,549,800)
Beginning balance (in shares) at Dec. 31, 2018           4,960,552                        
Beginning balance at Dec. 31, 2018 (12,709,539)         $ 49,606         0 18,477,598         451 (31,237,194)
Increase (Decrease) in Stockholders' Equity                                    
Foreign currency translation adjustment (451)                                  
Net loss (32,624,697)                                  
Ending balance (in shares) at Sep. 30, 2019           10,013,605                        
Ending balance at Sep. 30, 2019 (13,093,262)         $ 100,136         0 50,668,493         0 (63,861,891)
Beginning balance (in shares) at Mar. 31, 2019           4,960,552                        
Beginning balance at Mar. 31, 2019 (18,607,225)         $ 49,606         0 18,892,800         169 (37,549,800)
Increase (Decrease) in Stockholders' Equity                                    
Stock-based compensation expense 111,807                     111,807            
Foreign currency translation adjustment (169)                               (169)  
Conversion of debt (in shares)           1,125,673                        
Conversion of debt 13,979,789         $ 11,257           13,968,532            
Equity transactions (in shares)           157,743                        
Equity transactions 1,948,885         $ 1,577           1,947,308            
Net loss (3,538,810)                                 (3,538,810)
Ending balance (in shares) at Jun. 30, 2019           6,243,968                        
Ending balance at Jun. 30, 2019 (6,105,723)         $ 62,440         0 34,920,447         0 (41,088,610)
Increase (Decrease) in Stockholders' Equity                                    
Stock-based compensation expense 193,005                     193,005            
Foreign currency translation adjustment 0                                  
Equity transactions (in shares)                 1,576,655 2,192,982                
Equity transactions       $ 2,341,050 $ 13,251,687       $ 15,766 $ 21,930         $ 2,325,284 $ 13,229,757    
Net loss (22,773,281)                                 (22,773,281)
Ending balance (in shares) at Sep. 30, 2019           10,013,605                        
Ending balance at Sep. 30, 2019 (13,093,262)         $ 100,136         0 50,668,493         0 (63,861,891)
Beginning balance (in shares) at Dec. 31, 2019           52,746,728                        
Beginning balance at Dec. 31, 2019 11,018,411         $ 527,467         (47,864) 62,018,632         0 (51,479,824)
Increase (Decrease) in Stockholders' Equity                                    
Stock-based compensation expense 222,513                     222,513            
Net loss (3,943,819)                                 (3,943,819)
Ending balance (in shares) at Mar. 31, 2020           52,746,728                        
Ending balance at Mar. 31, 2020 7,297,105         $ 527,467         (47,864) 62,241,145         0 (55,423,643)
Beginning balance (in shares) at Dec. 31, 2019           52,746,728                        
Beginning balance at Dec. 31, 2019 11,018,411         $ 527,467         (47,864) 62,018,632         0 (51,479,824)
Increase (Decrease) in Stockholders' Equity                                    
Foreign currency translation adjustment 0                                  
Net loss (18,031,641)                                  
Ending balance (in shares) at Sep. 30, 2020           162,147,973                        
Ending balance at Sep. 30, 2020 14,421,645         $ 1,621,480         (47,864) 82,359,494         0 (69,511,465)
Beginning balance (in shares) at Mar. 31, 2020           52,746,728                        
Beginning balance at Mar. 31, 2020 7,297,105         $ 527,467         (47,864) 62,241,145         0 (55,423,643)
Increase (Decrease) in Stockholders' Equity                                    
Stock-based compensation expense 149,209                     149,209            
Conversion of debt (in shares)           21,920,820                        
Conversion of debt (4,977,876)         $ 219,208           (5,197,084)            
Equity transactions (in shares)             1,328,405 59,132,191                    
Equity transactions   $ 331,756 $ 15,436,808       $ 13,284 $ 591,322         $ 318,472 $ 14,845,486        
Net loss (3,613,975)                                 (3,613,975)
Ending balance (in shares) at Jun. 30, 2020           135,128,144                        
Ending balance at Jun. 30, 2020 14,623,027         $ 1,351,281         (47,864) 72,357,228         0 (59,037,618)
Increase (Decrease) in Stockholders' Equity                                    
Stock-based compensation expense 126,290                     126,290            
Foreign currency translation adjustment 0                                  
Equity transactions (in shares)               27,019,829                    
Equity transactions     $ 10,146,175         $ 270,199           $ 9,875,976        
Net loss (10,473,847)                                 (10,473,847)
Ending balance (in shares) at Sep. 30, 2020           162,147,973                        
Ending balance at Sep. 30, 2020 $ 14,421,645         $ 1,621,480         $ (47,864) $ 82,359,494         $ 0 $ (69,511,465)